Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment

Archives of Ophthalmology

Volumn 120, Issue 3, 2002, Pages 338-346

  Krzystolik, Magdalena G ^a   Afshari, Mehran A ^b   Adamis, Anthony P ^b   Gaudreault, Jacques ^c   Gragoudas, Evangelos S ^b   Michaud, Norman A ^b   Li, Wenjun ^b   Connolly, Edward ^b   O'Neill, Charles A ^c   Miller, Joan W ^b  

^a Retina Consultants   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; INTRAOCULAR HEMORRHAGE; NONHUMAN; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION;

EID: 0036129304     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.120.3.338     Document Type: Article

References (16)

1. Argon laser photocoagulation for senile macular degeneration: Results of a randomized clinical trial
2. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment
3. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization
4. Lutetium texaphyrin (Lu-Tex): A potential new agent for ocular fundus angiography and photodynamic therapy
5. Photophysical properties of tin ethyl etiopurpurin I (SnET2) and tin octaethylbenzochlorin (SnOEBC) in solution and bound to albumin
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration: One-year results of 2 randomized clinical trials - TAP report
7. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of re-treatments in a phase 1 and 2 study
8. Vascular endothelial growth factor, a specific regulator of angiogenesis
9. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor
10. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes
11. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
12. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate
13. Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 1251-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration
14. Pharmacokinetics and retinal distribution of AMD rhuFab V2 after intravitreal administration in rabbits
15. Safety evaluation of intravitreal administration of rhuFab VEGF in cynomolgus monkeys for 3 months
16. Subretinal neovascularization: Natural history of an experimental model